Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 3, 2014, Pages 518-525

  Yang, T Jonathan ^a   Oh, Jung Hun ^a   Folkert, Michael R ^a   Gupta, Gaorav ^a   Shi, Weiji ^a   Zhang, Zhigang ^a   Morikawa, Aki ^a   Seidman, Andrew ^a   Brennan, Cameron ^a   Yamada, Yoshiya ^a   Chan, Timothy A ^a   Beal, Kathryn ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAZARDS; MULTIVARIANT ANALYSIS; PATHOLOGY; RADIOTHERAPY;

CLINICAL PREDICTORS; KAPLAN-MEIER METHOD; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; PROBABILITY ESTIMATE; PROPORTIONAL HAZARDS; REGRESSION FUNCTION; STEREOTACTIC RADIOSURGERY;

DISEASES;

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;

ADULT; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LOCAL FAILURE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; RADIATION NECROSIS; REGIONAL FAILURE; RISK FACTOR; SALVAGE THERAPY; STEREOTACTIC RADIOSURGERY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME; ADVERSE EFFECTS; AGED; BRAIN NEOPLASMS; BREAST TUMOR; CHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; RADIOSURGERY; REGRESSION ANALYSIS; SECONDARY; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MIDDLE AGED; PROGNOSIS; RADIOSURGERY; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 84907982599     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.06.063     Document Type: Article

References (31)

1. J.S. Barnholtz-Sloan, A.E. Sloan, and F.G. Davis Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system J Clin Oncol 22 2004 2865 2872
2. R.J. Weil, D.C. Palmieri, and J.L. Bronder Breast cancer metastasis to the central nervous system Am J Pathol 167 2005 913 920
3. J.C. Bendell, S.M. Domchek, and H.J. Burstein Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma Cancer 97 2003 2972 2977
4. E. Shmueli, N. Wigler, and M. Inbar Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment Eur J Cancer 40 2004 379 382
5. H. Kennecke, R. Yerushalmi, and R. Woods Metastatic behavior of breast cancer subtypes J Clin Oncol 28 2010 3271 3277
6. R. Soffietti, R. Ruda, and E. Trevisan Brain metastases: Current management and new developments Curr Opin Oncol 20 2008 676 684
7. R.A. Patchell, P.A. Tibbs, and W.F. Regine Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial JAMA 280 1998 1485 1489
8. R.A. Patchell The management of brain metastases Cancer Treat Rev 29 2003 533 540
9. C. Brennan, T.J. Yang, and P. Hilden A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases Int J Radiat Oncol Biol Phys 88 2014 130 136
10. Expert Panel on Radiation Oncology-Brain Metastases G.M. Videtic, L.E. Gaspar, and A.M. Aref American College of Radiology appropriateness criteria on multiple brain metastases Int J Radiat Oncol Biol Phys 75 2009 961 965
11. P.K. Sneed, J.H. Suh, and S.J. Goetsch A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases Int J Radiat Oncol Biol Phys 53 2002 519 526
12. H. Aoyama, H. Shirato, and M. Tago Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial JAMA 295 2006 2483 2491
13. M. Kocher, R. Soffietti, and U. Abacioglu Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 study J Clin Oncol 29 2011 134 141
14. A.S. Mahmoud-Ahmed, J.H. Suh, and S.Y. Lee Results of whole brain radiotherapy in patients with brain metastases from breast cancer: A retrospective study Int J Radiat Oncol Biol Phys 54 2002 810 817
15. I. Karam, A. Nichol, and R. Woods Population-based outcomes after whole brain radiotherapy and re-irradiation in patients with metastatic breast cancer in the trastuzumab era Radiat Oncol 6 2011 181
16. E.L. Chang, and S. Lo Diagnosis and management of central nervous system metastases from breast cancer Oncologist 8 2003 398 410
17. L. Gaspar, C. Scott, and M. Rotman Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 1997 745 751
18. P.W. Sperduto, B. Berkey, and L.E. Gaspar A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database Int J Radiat Oncol Biol Phys 70 2008 510 514
19. P.W. Sperduto, N. Kased, and D. Roberge Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases Int J Radiat Oncol Biol Phys 82 2012 2111 2117
20. E. Shaw, R. Kline, and M. Gillin Radiation Therapy Oncology Group: Radiosurgery quality assurance guidelines Int J Radiat Oncol Biol Phys 27 1993 1231 1239
21. E. Shaw, C. Scott, and L. Souhami Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05 Int J Radiat Oncol Biol Phys 47 2000 291 298
22. M. Gonen, and G. Heller Concordance probability and discriminatory power in proportional hazards regression Biometrika 92 2005 965 970
23. Z. Gabos, R. Sinha, and J. Hanson Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer J Clin Oncol 24 2006 5658 5663
24. Y.L. Tham, K. Sexton, and R. Kramer Primary breast cancer phenotypes associated with propensity for central nervous system metastases Cancer 107 2006 696 704
25. E.L. Chang, J.S. Wefel, and K.R. Hess Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial Lancet Oncol 10 2009 1037 1044
26. S.S. Lee, J.H. Ahn, and M.K. Kim Brain metastases in breast cancer: Prognostic factors and management Breast Cancer Res Treat 111 2008 523 530
27. B.E. Amendola, A.L. Wolf, and S.R. Coy Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast Cancer J 6 2000 88 92
28. S. Akyurek, E.L. Chang, and A. Mahajan Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer Am J Clin Oncol 30 2007 310 314
29. D. Kondziolka, H. Kano, and G.L. Harrison Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article J Neurosurg 114 2011 792 800
30. D.J. Slamon, B. Layland-Jones, and S. Shak Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783 792
31. M.A. Dyer, P.J. Kelly, and Y.H. Chen Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases Int J Radiat Oncol Biol Phys 83 2012 e479 e486